NCT01469247
- Conditions
- Brain Cancer, Brain Diseases, Brain Neoplasms, +20 more
- Locations
-
- Orlando Health Orlando, Florida, United States
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Neuroectodermal Tumors
Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.
6,013 public trials
1,222 recruiting studies
Neuroectodermal Tumors trial results
Completed
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome
NCT00774930
- Conditions
- Adenocarcinoma, Carcinoid Syndrome, Carcinoid Tumor, +17 more
- Locations
-
- VA Greater Los Angeles Health Care System Los Angeles, California, United States
- David Geffen School of Medicine at UCLA Los Angeles, California, United States
- Stanford Cancer Center Stanford, California, United States
- Cedars Sinai Outpatient Cancer Center West Hollywood, California, United States
NCT02357992
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +19 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT03396952
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
- Locations
-
- University of Califonia, San Francisco San Francisco, California, United States
NCT00199901
- Conditions
- Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
- Locations
-
- Sydney Melanoma Unit - Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Newcastle Melanoma Unit - Newcastle Mater Misericordiae Hospital Newcastle, New South Wales, Australia
- Mater Medical Centre, Princess Alexandra Hospital Woolloongabba, Queensland, Australia
- Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia
Completed
Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors
NCT04172454
- Conditions
- Advanced Solid Tumors, Melanoma, Neoplasms, +10 more
- Locations
-
- Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
NCT02336165
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +7 more
- Locations
-
- Research Facility Los Angeles, California, United States
- Research Facility San Francisco, California, United States
- Research Facility Baltimore, Maryland, United States
- Research Facility Boston, Massachusetts, United States
Completed
Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma
NCT00679289
- Conditions
- Cutaneous Melanoma, Melanoma, Metastatic Melanoma, +11 more
- Locations
-
- University of Chicago Hospital Chicago, Illinois, United States
- University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
NCT00842348
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- Cedars-Sinai Outpatient Cancer Center Los Angeles, California, United States
- The Johns Hopkins Hospital Baltimore, Maryland, United States
- UZ Antwerpen Antwerp, Belgium
- UCL Saint Luc Brussels, Belgium
NCT00142454
- Conditions
- Malignant Melanoma, Melanoma, Neoplasms, +10 more
- Locations
-
- NYU Cancer Institute New York, United States